©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 95905
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95905
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95905
Table 1 Causes of hyperkalemia in kidney transplant recipients
| Category | Examples |
| Type of transplant | Combined kidney-pancreas |
| Immunosuppressive medications | Cyclosporine |
| Tacrolimus | |
| Non-immunosuppressive medications | Angiotensin-converting enzyme inhibitors |
| Angiotensin II receptor blockers | |
| Beta-blockers | |
| Steroidal mineralocorticoid antagonists (eplerenone, spironolactone) | |
| Non-steroidal mineralocorticoid antagonists (finerenone) | |
| Potassium-sparing diuretics (amiloride, triamterene) | |
| Heparin | |
| Mannitol | |
| Non-steroidal anti-inflammatory drugs | |
| Pneumocystis jirovecii pneumonia prophylactic agents (pentamidine, trimethoprim-sulfamethoxazole) | |
| Succinylcholine | |
| Others | Interstitial fibrosis and tubular atrophy |
| Delayed graft function | |
| Dietary indiscretion1 | |
| Hyperglycemia | |
| Metabolic acidosis | |
| Type 4 renal tubular acidosis | |
| Urinary tract obstruction |
- Citation: Aboghanem A, Prasad GVR. Disorders of potassium homeostasis after kidney transplantation. World J Transplant 2024; 14(3): 95905
- URL: https://www.wjgnet.com/2220-3230/full/v14/i3/95905.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i3.95905